Advertisement
HCM vs SNDL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCM is a StrongBuy and SNDL is a StrongBuy.
Momentum Indicator for HCM turns positive, indicating new upward trend
HCM saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 65 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The 50-day moving average for HCM moved above the 200-day moving average on October 14, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +4.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCM advanced for three days, in 197 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
HCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 131 of 183 cases where HCM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for HCM turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 39 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. HCM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.969) is normal, around the industry mean (10.407). HCM has a moderately high P/E Ratio (142.800) as compared to the industry average of (-6.173). Projected Growth (PEG Ratio) (4.030) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (4.268) is also within normal values, averaging (178.797).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
SNDL's RSI Oscillator recovers from oversold territory
The RSI Indicator for SNDL moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 29 of the 34 cases the stock moved higher. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on SNDL as a result. In 69 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for SNDL just turned positive on October 20, 2026. Looking at past instances where SNDL's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.
Following a +2.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNDL advanced for three days, in 142 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
SNDL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
SNDL moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SNDL crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNDL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for SNDL entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.298) is normal, around the industry mean (4.788). P/E Ratio (-16.125) is within average values for comparable stocks, (63.088). SNDL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.650). Dividend Yield (0.000) settles around the average of (0.080) among similar stocks. P/S Ratio (0.536) is also within normal values, averaging (4.786).
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. SNDL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNDL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.
HCM | SNDL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 85 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 81 | 91 | |
PRICE GROWTH RATING 1..100 | 44 | 62 | |
P/E GROWTH RATING 1..100 | 1 | 42 | |
SEASONALITY SCORE 1..100 | 50 | 37 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SNDL's Valuation (15) in the null industry is significantly better than the same rating for HCM (90) in the Pharmaceuticals Major industry. This means that SNDL’s stock grew significantly faster than HCM’s over the last 12 months.
SNDL's Profit vs Risk Rating (100) in the null industry is in the same range as HCM (100) in the Pharmaceuticals Major industry. This means that SNDL’s stock grew similarly to HCM’s over the last 12 months.
HCM's SMR Rating (81) in the Pharmaceuticals Major industry is in the same range as SNDL (91) in the null industry. This means that HCM’s stock grew similarly to SNDL’s over the last 12 months.
HCM's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as SNDL (62) in the null industry. This means that HCM’s stock grew similarly to SNDL’s over the last 12 months.
HCM's P/E Growth Rating (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNDL (42) in the null industry. This means that HCM’s stock grew somewhat faster than SNDL’s over the last 12 months.
| HCM | SNDL | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 85% |
| Stochastic ODDS (%) | 1 day ago 74% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 76% | 1 day ago 77% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 78% |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 81% |
| Advances ODDS (%) | 3 days ago 71% | 3 days ago 70% |
| Declines ODDS (%) | 1 day ago 77% | 9 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 68% | 1 day ago 76% |
| Aroon ODDS (%) | 1 day ago 72% | 1 day ago 76% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HCM’s FA Score shows that 1 FA rating(s) are green while SNDL’s FA Score has 1 green FA rating(s).
- HCM’s FA Score: 1 green, 4 red.
- SNDL’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HCM’s TA Score shows that 5 TA indicator(s) are bullish while SNDL’s TA Score has 5 bullish TA indicator(s).
- HCM’s TA Score: 5 bullish, 3 bearish.
- SNDL’s TA Score: 5 bullish, 5 bearish.
Price Growth
HCM (@Pharmaceuticals: Generic) experienced а +6.60% price change this week, while SNDL (@Beverages: Alcoholic) price change was +6.61% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.
The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was +2.58%. For the same industry, the average monthly price growth was -1.40%, and the average quarterly price growth was -24.03%.
Reported Earning Dates
HCM is expected to report earnings on Nov 13, 2026.
SNDL is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-2.94% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Beverages: Alcoholic (+2.58% weekly)The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.
Advertisement
HCM and
Correlation & Price change
A.I.dvisor tells us that HCM and ACET have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and ACET's prices will move in lockstep.
| Ticker / NAME | Correlation To HCM | 1D Price Change % | ||
|---|---|---|---|---|
| HCM | 100% | -0.63% | ||
| ACET - HCM | 29% Poorly correlated | -4.68% | ||
| CGC - HCM | 27% Poorly correlated | -1.00% | ||
| GELS - HCM | 25% Poorly correlated | -2.23% | ||
| SNDL - HCM | 25% Poorly correlated | +0.78% | ||
| RMTI - HCM | 23% Poorly correlated | -0.28% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UST | 39.57 | 0.80 | +2.06% |
| ProShares Ultra 7-10 Year Treasury (UST) | |||
| MINO | 43.66 | 0.38 | +0.88% |
| PIMCO Municipal Income Opportunities Active Exchange-Traded Fund (MINO) | |||
| IUSV | 115.67 | 0.65 | +0.57% |
| iShares Core S&P US Value ETF (IUSV) | |||
| RISN | 30.60 | -0.09 | -0.31% |
| Inspire Capital Appreciation ETF (RISN) | |||
| GDIV | 18.39 | -0.11 | -0.62% |
| Harbor Dividend Growth Leaders ETF (GDIV) | |||